| Dr Nicola J Cherry, MD | |
|
2580 Daggett Ave, Klamath Falls, OR 97601-1127 | |
| (541) 884-1224 | |
| (541) 884-8030 |
| Full Name | Dr Nicola J Cherry |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 2580 Daggett Ave, Klamath Falls, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508812207 | NPI | - | NPPES |
| 288475 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD21778 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nicola J Cherry, MD Po Box 5109, Klamath Falls, OR 97601-0119 Ph: (541) 882-1540 | Dr Nicola J Cherry, MD 2580 Daggett Ave, Klamath Falls, OR 97601-1127 Ph: (541) 884-1224 |
News Archive
The New York Times: "The UnitedHealth Group, one of the nation's largest health insurers, is teaming up with the Y.M.C.A. and retail pharmacies to try a new approach to one of the nation's most serious and expensive medical problems: Type 2 Diabetes. Rather than simply continuing to pay ever-higher medical claims to care for its diabetic customers, UnitedHealth is paying the Y.M.C.A. and pharmacists to keep people healthier."
In this PLoS "Speaking of Medicine" blog post, Julien Potet and Katy Athersuch of Medecins Sans Frontieres' (MSF) Access Campaign say that the WHO's decision last week to "simply continue monitoring" the medical research and development (R&D) industry's ability to address the needs of people living in developing countries "by creating a global R&D 'observatory'" is "a deeply disappointing outcome that will not help re-shape priorities, increase funding or catalyze development of urgently needed new medical tools; at best it will only underscore further how badly these actions are needed."
A study in February's Journal of Vascular and Interventional Radiology found that patients undergoing liver cancer treatment with Theraspheres?, radioactive microspheres containing Yittrium-90, can tolerate a 150 Gy single dose or 268 Gy repeated dose without risk of radiation-induced liver disease.
The Center for Applied Medical Research (CIMA) from the University of Navarra and the Amsterdam Molecular Therapeutics BV (AMT) have demonstrated the pre-clinical effectiveness of a treatment against acute intermittent porphyria.
› Verified 3 days ago
Dr. Carrie Atwell Ganong, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3001 Daggett Ave, Klamath Falls, OR 97601 Phone: 541-851-4800 Fax: 541-851-4801 | |
Charles Michael Labuwi, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2310 Mountain View Blvd, Klamath Falls, OR 97601 Phone: 541-883-3591 Fax: 541-883-2886 | |
Dr. Frederick L Zwartverwer, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3001 Daggett Ave, Klamath Falls, OR 97601 Phone: 541-851-4800 Fax: 541-851-4801 | |
John Aaron Wilson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3001 Daggett Ave, Klamath Falls, OR 97601 Phone: 541-851-4800 Fax: 541-851-4801 | |
Tracy Warwick Graham, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 706 Main St Ste 2a, Klamath Falls, OR 97601 Phone: 541-851-7350 Fax: 541-851-7351 |